乙型肝炎后肝硬化患者血清可溶性白介素-2受体水平的变化  

Serum soluble interleukin-2 receptor levels in patients with posthepatitis-B cirrhosis.

作　　者：徐秀英[1] 迟晶[1] 石田[1] 杨澍[2] 张艳晨 

机构地区：[1]中国医科大学第一附属医院消化内科,沈阳110001 [2]深圳市宝安区人民医院 [3]沈阳市公安医院

出　　处：《中国实用内科杂志》2002年第11期657-658,共2页Chinese Journal of Practical Internal Medicine

摘　　要：目的　了解肝炎后肝硬化患者血清可溶性白介素 2受体 (sIL 2R)水平的变化及其与肝炎活动的相关性。方法　采用酶联免疫法测定 3 7例乙型肝炎后肝硬化患者血清sIL 2R水平。结果　乙型肝炎后肝硬化患者血清sIL 2R水平显著增高 (P <0 0 1) ,并与血清丙氨酸转氨酶水平呈正相关 (r =0 3 8,P <0 0 5 )。结论　检测血清sILObjective To determine serum soluble interleukin 2 receptor level in patients with posthepatitis B liver cirrhosis.Methods Serum sIL 2R was measured using enzyme linked immunosorbent assay.Results Serum sIL 2R was significantly higher in patients with posthepatitis B cirrhosis than that in controls(P<0\^01),and the sIL 2R level was positively correlated with alanine aminotransferase(ALT)(r=0\^38,P<0\^05).Conclusion Determining serum sIL 2R level is valuable for evaluating the immune function.

关 键 词：乙型肝炎后肝硬化 可溶性白介素-2受体 ELISA 

分 类 号：R512.62[医药卫生—内科学]